{
  "case_id": "Case_5",
  "model_id": "qwen/qwen-2.5-coder-32b-instruct",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Parkinson's Disease\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"G20.9\",\n        \"reasoning\": \"Progressive neurological symptoms including tremor, bradykinesia, and rigidity, with onset 6 months post-exposure to rural Bangladesh, typical of idiopathic PD. MRI shows subtle basal ganglia abnormalities consistent with PD.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Manganism\",\n            \"confidence\": 0.15,\n            \"icd_code\": \"G12.1\",\n            \"reasoning\": \"Exposure to environmental toxins in rural Bangladesh could include manganism if there was exposure to manganese compounds, though this is less likely given the typical 10-20 year latency.\"\n        },\n        {\n            \"name\": \"Essential Tremor\",\n            \"confidence\": 0.05,\n            \"icd_code\": \"G10\",\n            \"reasoning\": \"Dominant tremor, though usually does not present with bradykinesia or rigidity. However, it's important to rule out given the patient's self-research.\"\n        },\n        {\n            \"name\": \"Drug-Induced Parkinsonism\",\n            \"confidence\": 0.0,\n            \"icd_code\": \"G23\",\n            \"reasoning\": \"No known medications used by the patient that could cause Parkinsonism.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Progressive tremor, bradykinesia, rigidity\",\n        \"Subtle signal abnormalities in basal ganglia on MRI\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Blood Test for Manganese Levels\",\n            \"purpose\": \"To rule in or out manganism\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"CSF Analysis\",\n            \"purpose\": \"To rule out other causes of Parkinsonism\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Neurological Exam\",\n            \"purpose\": \"To confirm and characterize the clinical features\",\n            \"priority\": \"immediate\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Perform neurological exam\",\n            \"Order initial diagnostic tests\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Levodopa\",\n                \"dose\": \"25mg PO\",\n                \"route\": \"PO\",\n                \"duration\": \"As needed\",\n                \"rationale\": \"Standard treatment for Parkinson's Disease\"\n            }\n        ],\n        \"monitoring\": [\n            \"Motor symptoms response to medication\",\n            \"Weekly\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Neurology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Specialist consultation for definitive diagnosis and management\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Worsening symptoms despite therapy\",\n        \"New neurological deficits\"\n    ],\n    \"patient_education\": [\n        \"Importance of regular follow-up\",\n        \"Understanding of disease progression and treatment options\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"In 2 weeks\",\n        \"conditions\": \"Immediate return if new symptoms or concerns arise\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Exposure to specific environmental toxins in Bangladesh\",\n        \"Longitudinal neurological changes\"\n    ]\n}",
  "latency": 14.953239917755127,
  "timestamp": "2025-08-10T01:18:45.193112",
  "cached_at": "2025-08-10T01:18:45.193116"
}